Bank of America
DNA.WS

Bank of America’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

Bank of America’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-120
Closed -$31 – 8007
2023
Q2 		$31 Hold
120
– – ﹤0.01% 7495
2023
Q1 		$22 Buy
+120
New +$27 ﹤0.01% 7567
2022
Q3 		– Sell
-100
Closed – – 8291
2022
Q2 		$0 Buy
100
+80
+400% +$51 ﹤0.01% 8514
2022
Q1 		$0 Buy
+20
New +$22 ﹤0.01% 8901

Other funds holding DNA.WS

LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
JRCM
Jones Road Capital Management New York $55.3M AUM 29.97% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Bank of America's DNA.WS Position: Q3 2023 in Review

Bank of America sold out of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) in Q3 2023, closing a stake of 120 shares — an estimated $31 sold.

Bank of America first reported a position in DNA.WS in Q1 2022 and held it in 4 quarters. The position peaked at $31 in Q2 2023. 33 funds tracked by Wall St. Rank hold DNA.WS as of Q3 2023.

  • Bank of America reported no remaining Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position as of Q3 2023 after selling out during the quarter.
  • Bank of America sold 120 Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share shares in Q3 2023, an estimated $31.
  • Bank of America first reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q1 2022 and held it in 4 quarters.
  • Bank of America's Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position peaked at $31 in Q2 2023.
  • 33 funds tracked by Wall St. Rank held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share as of Q3 2023.

Based on Bank of America's 13F filing for Q3 2023, filed 14 Nov 2023.